Henan Taloph Pharmaceutical Stock (600222.SS) Earnings Analysis
Henan Taloph Pharmaceutical Stock (600222.SS) has no confirmed upcoming earnings date. Trailing P/E 64.03.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 600222.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 600222.SS. This page updates as the calendar is published.
600222.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-06-30 | 0.03259 CNY | n/a | n/a | n/a |
| 2025-03-31 | 0.0028 CNY | n/a | n/a | n/a |
| 2024-12-31 | 0.03903 CNY | n/a | n/a | n/a |
600222.SS valuation and analyst view
| Trailing P/E | 64.03 |
|---|---|
| Trailing EPS | 0.11044 CNY |
| Price / book | 2.43 |
| Dividend yield | 0.20% |
| Market cap | 3.90B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Henan Taloph Pharmaceutical Stock (600222.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 600222.SS. This page updates as the calendar is published.
Did 600222.SS beat earnings last quarter?
Consensus estimate data was not available for 600222.SS's 2025-06-30 report.
What is 600222.SS's current P/E ratio and EPS?
600222.SS trades at a trailing P/E of 64.03 on trailing EPS of 0.11044319048538134 CNY.
What do analysts rate 600222.SS?
600222.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.